IDiyas

For the Inventor, By the Inventor

San Mateo, CA, United States of America

Angie Inyoung Kim

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 13.5

ph-index = 5

Forward Citations = 95(Granted Patents)


Company Filing History:

goldMedal11 out of 173 
 
Exelixis, Inc.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 2009-2023

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 11597699 - MEK inhibitors and methods of their use (2023-03-07),
2. 8697737 - Raf modulators and methods of use (2014-04-15),
3. 8648066 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture (2014-02-11),
4. 8637499 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture (2014-01-28),
5. 8372851 - Pyrazolo pyrimidines as casein kinase II (CK2) modulators (2013-02-12),
6. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases (2013-01-29),
7. 8012956 - Tropane compounds (2011-09-06),
8. 7915250 - Azetidines as MEK inhibitors for the treatment of proliferative diseases (2011-03-29),
9. 7872014 - Anaplastic lymphoma kinase modulators and methods of use (2011-01-18),
10. 7846959 - Raf modulators and methods of use (2010-12-07),
11. 7803839 - Azetidines as MEK inhibitors for the treatment of proliferative diseases (2010-09-28),
12. 7576074 - Receptor-type kinase modulators and methods of use (2009-08-18),

Title: Innovations by Angie Inyoung Kim: Pioneering MEK Inhibitors and Raf Modulators

Introduction

Angie Inyoung Kim is a prolific inventor based in San Mateo, California, recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, she has made noteworthy advancements in the treatment of various proliferative diseases, particularly cancer.

Latest Patents

Among her latest patents, Angie has developed innovative MEK inhibitors. These compounds are defined by a specific formula that includes pharmaceutically acceptable salts and solvates, demonstrating potential in treating proliferative diseases, including cancer. In addition, she has worked on Raf modulators, which are designed to inhibit and modulate protein kinase enzymatic activity. This invention aids in regulating cellular processes such as proliferation and differentiation, which are crucial in managing kinase-dependent diseases.

Career Highlights

Throughout her career, Angie has been associated with prominent companies such as Exelixis, Inc. Her expertise in pharmaceutical development has positioned her at the forefront of innovation in cancer treatment methodologies. Her patented inventions are a testament to her dedication and knowledge in the biomedical field.

Collaborations

Angie Inyoung Kim has collaborated with various professionals, including notable coworkers Joerg Bussenius and Csaba J. Peto. These collaborations have contributed to her success in advancing the understanding and treatment of complex diseases.

Conclusion

Angie Inyoung Kim's innovative work continues to pave the way for new therapeutic options in the battle against cancer. With her extensive patent portfolio and dedication to scientific advancement, she remains a key figure in the realm of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…